Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Sales (2024 - 2025)

Historic Return on Sales for Krystal Biotech (KRYS) over the last 4 years, with Q3 2025 value amounting to 0.81%.

  • Krystal Biotech's Return on Sales rose 4900.0% to 0.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 3200.0%. This contributed to the annual value of 0.31% for FY2024, which is 900.0% up from last year.
  • Krystal Biotech's Return on Sales amounted to 0.81% in Q3 2025, which was up 4900.0% from 0.4% recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Return on Sales ranged from a high of 46.63% in Q4 2021 and a low of 0.02% during Q1 2024
  • Moreover, its 4-year median value for Return on Sales was 0.4% (2025), whereas its average is 6.32%.
  • In the last 5 years, Krystal Biotech's Return on Sales tumbled by -91100bps in 2024 and then surged by 4900bps in 2025.
  • Krystal Biotech's Return on Sales (Quarter) stood at 46.63% in 2021, then tumbled by -100bps to 0.21% in 2023, then skyrocketed by 142bps to 0.5% in 2024, then skyrocketed by 62bps to 0.81% in 2025.
  • Its Return on Sales was 0.81% in Q3 2025, compared to 0.4% in Q2 2025 and 0.4% in Q1 2025.